Literature DB >> 22343409

Normal myofibrillar development followed by progressive sarcomeric disruption with actin accumulations in a mouse Cfl2 knockout demonstrates requirement of cofilin-2 for muscle maintenance.

Pankaj B Agrawal1, Mugdha Joshi, Talia Savic, Zoe Chen, Alan H Beggs.   

Abstract

Cofilin-2, a small actin-binding protein and member of the AC protein family that includes cofilin-1 and destrin, is predominantly expressed at sarcomeres in skeletal and cardiac muscles. The role of cofilin-2 in muscle development and function is unclear. In humans, recessive cofilin-2 mutations have been associated with nemaline myopathy with minicores. To investigate the functional role of cofilin-2 in vivo, we generated constitutive and muscle-specific cofilin-2-deficient mice using a cre-loxP strategy. Cofilin-2-deficient mice were similar to their wild-type (WT) littermates at birth, but died by day 8. They were significantly smaller, severely weak and had very little milk in their stomachs. The sarcomeric structure was intact at birth, but by Day 7, skeletal muscles showed severe sarcomeric disruptions starting at the Z-line, along with filamentous actin accumulations consistent with a lack of actin depolymerization activity. Cofilin-2-deficient muscles contained elevated numbers of slow fibers and exhibited upregulation of slow fiber-specific genes. Increased amounts of other sarcomeric proteins including α-actinin-2, α-sarcomeric actin and tropomyosin were also present. While destrin was not expressed in either WT or cofilin-2-deficient muscles, cofilin-1 was similarly expressed in developing myofibers of both genotypes. There was no evidence for compensatory changes in expression of either family member in cofilin-2-deficient tissues. The onset of pathology and weakness in cofilin-2-deficient muscles correlated with normal developmental loss of cofilin-1 expression within myofibers, suggesting that cofilin-1 serves as an early developmental sarcomeric isoform. Overall, cofilin-2, although not critical for muscle development, is essential for muscle maintenance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22343409      PMCID: PMC3335316          DOI: 10.1093/hmg/dds053

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

Review 1.  Proteins of the ADF/cofilin family: essential regulators of actin dynamics.

Authors:  J R Bamburg
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy.

Authors:  M Mills; N Yang; R Weinberger; D L Vander Woude; A H Beggs; S Easteal; K North
Journal:  Hum Mol Genet       Date:  2001-06-15       Impact factor: 6.150

3.  The three mouse actin-depolymerizing factor/cofilins evolved to fulfill cell-type-specific requirements for actin dynamics.

Authors:  Maria K Vartiainen; Tuija Mustonen; Pieta K Mattila; Pauli J Ojala; Irma Thesleff; Juha Partanen; Pekka Lappalainen
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

4.  A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy.

Authors:  M A Corbett; C S Robinson; G F Dunglison; N Yang; J E Joya; A W Stewart; C Schnell; P W Gunning; K N North; E C Hardeman
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

5.  Cofilin-2, a novel type of cofilin, is expressed specifically at aggregation stage of Dictyostelium discoideum development.

Authors:  H Aizawa; Y Kishi; K Iida; M Sameshima; I Yahara
Journal:  Genes Cells       Date:  2001-10       Impact factor: 1.891

6.  RYR1 mutations are a common cause of congenital myopathies with central nuclei.

Authors:  J M Wilmshurst; S Lillis; H Zhou; K Pillay; H Henderson; W Kress; C R Müller; A Ndondo; V Cloke; T Cullup; E Bertini; C Boennemann; V Straub; R Quinlivan; J J Dowling; S Al-Sarraj; S Treves; S Abbs; A Y Manzur; C A Sewry; F Muntoni; Heinz Jungbluth
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

7.  Characterization of human muscle type cofilin (CFL2) in normal and regenerating muscle.

Authors:  C Thirion; R Stucka; B Mendel; A Gruhler; M Jaksch; K J Nowak; N Binz; N G Laing; H Lochmüller
Journal:  Eur J Biochem       Date:  2001-06

8.  Expression of cofilin isoforms during development of mouse striated muscles.

Authors:  K Mohri; H Takano-Ohmuro; H Nakashima; K Hayakawa; T Endo; K Hanaoka; T Obinata
Journal:  J Muscle Res Cell Motil       Date:  2000-01       Impact factor: 2.698

9.  Cofilin/ADF is required for cell motility during Drosophila ovary development and oogenesis.

Authors:  J Chen; D Godt; K Gunsalus; I Kiss; M Goldberg; F A Laski
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

10.  Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology.

Authors:  Y W Chen; P Zhao; R Borup; E P Hoffman
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

View more
  39 in total

Review 1.  The role of cyclase-associated protein in regulating actin filament dynamics - more than a monomer-sequestration factor.

Authors:  Shoichiro Ono
Journal:  J Cell Sci       Date:  2013-08-01       Impact factor: 5.285

2.  Knockin mouse model of the human CFL2 p.A35T mutation results in a unique splicing defect and severe myopathy phenotype.

Authors:  Samantha M Rosen; Mugdha Joshi; Talia Hitt; Alan H Beggs; Pankaj B Agrawal
Journal:  Hum Mol Genet       Date:  2020-07-29       Impact factor: 6.150

3.  Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.

Authors:  Jennifer Tinklenberg; Hui Meng; Lin Yang; Fujun Liu; Raymond G Hoffmann; Mahua Dasgupta; Kenneth P Allen; Alan H Beggs; Edna C Hardeman; R Scott Pearsall; Robert H Fitts; Michael W Lawlor
Journal:  Am J Pathol       Date:  2016-04-18       Impact factor: 4.307

4.  Cofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy.

Authors:  Khaushik Subramanian; Davide Gianni; Cristina Balla; Gabriele Egidy Assenza; Mugdha Joshi; Marc J Semigran; Thomas E Macgillivray; Jennifer E Van Eyk; Giulio Agnetti; Nazareno Paolocci; James R Bamburg; Pankaj B Agrawal; Federica Del Monte
Journal:  J Am Coll Cardiol       Date:  2015-03-31       Impact factor: 24.094

Review 5.  Regulation of structure and function of sarcomeric actin filaments in striated muscle of the nematode Caenorhabditis elegans.

Authors:  Shoichiro Ono
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

6.  Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation.

Authors:  Maria Chatzifrangkeskou; David Yadin; Thibaut Marais; Solenne Chardonnet; Mathilde Cohen-Tannoudji; Nathalie Mougenot; Alain Schmitt; Silvia Crasto; Elisa Di Pasquale; Coline Macquart; Yannick Tanguy; Imen Jebeniani; Michel Pucéat; Blanca Morales Rodriguez; Wolfgang H Goldmann; Matteo Dal Ferro; Maria-Grazia Biferi; Petra Knaus; Gisèle Bonne; Howard J Worman; Antoine Muchir
Journal:  Hum Mol Genet       Date:  2018-09-01       Impact factor: 6.150

7.  Cofilin-2 controls actin filament length in muscle sarcomeres.

Authors:  Elena Kremneva; Maarit H Makkonen; Aneta Skwarek-Maruszewska; Gergana Gateva; Alphee Michelot; Roberto Dominguez; Pekka Lappalainen
Journal:  Dev Cell       Date:  2014-10-27       Impact factor: 12.270

8.  Striated Preferentially Expressed Protein Kinase (SPEG)-Deficient Skeletal Muscles Display Fewer Satellite Cells with Reduced Proliferation and Delayed Differentiation.

Authors:  Qifei Li; Jasmine Lin; Samantha M Rosen; Tian Zhang; Shideh Kazerounian; Shiyu Luo; Pankaj B Agrawal
Journal:  Am J Pathol       Date:  2020-09-11       Impact factor: 4.307

9.  Rapid nucleotide exchange renders Asp-11 mutant actins resistant to depolymerizing activity of cofilin, leading to dominant toxicity in vivo.

Authors:  Nobuhisa Umeki; Jun Nakajima; Taro Q P Noguchi; Kiyotaka Tokuraku; Akira Nagasaki; Kohji Ito; Keiko Hirose; Taro Q P Uyeda
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

10.  TIRF microscopy analysis of human Cof1, Cof2, and ADF effects on actin filament severing and turnover.

Authors:  Samantha M Chin; Silvia Jansen; Bruce L Goode
Journal:  J Mol Biol       Date:  2016-03-17       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.